Aprea Therapeutics, Inc. (NASDAQ:APRE) IPO

Aprea Therapeutics, Inc.

IPO

Priced at US$15.00 a share on Oct 2, 2019.

Price
US$15.00 a share
Shares offered
5,666,667 shares of common stock
Offering size
US$85 million
Underwriters' option
Up to 850,000 more shares
Listing
APRE on the Nasdaq Global Select Market
Underwriters
J.P. Morgan, Morgan Stanley, RBC Capital Markets · In the order on the cover
Shares delivered
On or about Oct 7, 2019

Steps

StepWhen
Draft sent to the SEC in confidenceJul 12, 2019
Filed publiclySep 6, 2019
Amended 4 timesNewest Oct 2, 2019
Shares registered with an exchangeSep 30, 2019
Declared effective by the SECOct 2, 2019
Final prospectus, with the priceOct 4, 2019

From the cover of the final prospectus (424B4) filed Oct 4, 2019